Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Recommendations for the generation, quantification, storage and handling of peptides used for mass spectrometry-based assays

Journal Article · · Clinical Chemistry
The Clinical Proteomic Tumor Analysis Consortium (1) (CPTAC) of the National Cancer Institute (NCI) is a comprehensive and coordinated effort to accelerate the understanding of the molecular basis of cancer through the application of robust technologies and workflows for the quantitative measurements of proteins. The Assay Development Working Group of the CPTAC Program aims to foster broad uptake of targeted mass spectrometry-based assays employing isotopically labeled peptides for confident assignment and quantification, including multiple reaction monitoring (MRM; also referred to as Selected Reaction Monitoring), parallel reaction monitoring (PRM), and other targeted methods.
Research Organization:
Pacific Northwest National Laboratory (PNNL), Richland, WA (US), Environmental Molecular Sciences Laboratory (EMSL)
Sponsoring Organization:
USDOE
DOE Contract Number:
AC05-76RL01830
OSTI ID:
1243179
Report Number(s):
PNNL-SA-113208; 48666; 400412000
Journal Information:
Clinical Chemistry, Journal Name: Clinical Chemistry Journal Issue: 1 Vol. 62; ISSN 0009-9147
Country of Publication:
United States
Language:
English

Similar Records

Using the CPTAC Assay Portal to identify and implement highly characterized targeted proteomics assays
Book · Thu Feb 11 23:00:00 EST 2016 · OSTI ID:1327159

CPTAC Assay Portal: a repository of targeted proteomic assays
Journal Article · Fri Jun 27 00:00:00 EDT 2014 · Nature Methods, 11(7):703-704 · OSTI ID:1172461

Targeted proteomic assays for quantitation of proteins identified by proteogenomic analysis of ovarian cancer
Journal Article · Tue Jul 18 20:00:00 EDT 2017 · Scientific Data · OSTI ID:1375373